| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine kinase activity | CDC42BPG TRIO KALRN MKNK2 OBSCN LMTK3 MAP3K3 MAP3K4 SBK1 CIITA NRK MAP3K9 PNCK CDK3 | 1.75e-06 | 363 | 163 | 14 | GO:0106310 |
| GeneOntologyMolecularFunction | acetylcholine receptor regulator activity | 2.38e-06 | 27 | 163 | 5 | GO:0030548 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor regulator activity | 2.88e-06 | 28 | 163 | 5 | GO:0099602 | |
| GeneOntologyMolecularFunction | protein kinase activity | CDC42BPG HK1 TRIO KALRN MKNK2 OBSCN LMTK3 MAP3K3 MAP3K4 SBK1 CIITA COQ8A EPHA2 NRK MAP3K9 PNCK CDK3 | 8.71e-06 | 600 | 163 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | protein kinase binding | SOX9 ANK2 DSCAM FRS2 CASQ2 SPDYE18 ADCY6 AXIN1 MAVS NFATC1 CSPG4 SPDYE2 SPDYE21 SPDYE5 SCRIB SPDYE2B CDH2 TOP2A RFPL3 SPDYE6 SPDYE16 | 9.12e-06 | 873 | 163 | 21 | GO:0019901 |
| GeneOntologyMolecularFunction | kinase binding | SOX9 ANK2 WWC3 DSCAM FRS2 CASQ2 SPDYE18 ADCY6 AXIN1 MAVS NFATC1 CSPG4 SPDYE2 SPDYE21 SPDYE5 SCRIB SPDYE2B CDH2 TOP2A RFPL3 SPDYE6 SPDYE16 | 1.35e-05 | 969 | 163 | 22 | GO:0019900 |
| GeneOntologyMolecularFunction | N-acetylglucosamine 6-O-sulfotransferase activity | 1.82e-05 | 7 | 163 | 3 | GO:0001517 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CDC42BPG TRIO KALRN MKNK2 OBSCN LMTK3 MAP3K3 MAP3K4 SBK1 CIITA NRK MAP3K9 PNCK CDK3 | 1.84e-05 | 446 | 163 | 14 | GO:0004674 |
| GeneOntologyMolecularFunction | kinase activity | CDC42BPG HK1 TRIO KALRN MKNK2 OBSCN LMTK3 TRRAP MAP3K3 MAP3K4 SBK1 CIITA COQ8A EPHA2 NRK MAP3K9 PNCK CDK3 | 5.45e-05 | 764 | 163 | 18 | GO:0016301 |
| GeneOntologyMolecularFunction | very long-chain fatty acyl-CoA hydrolase activity | 6.62e-05 | 2 | 163 | 2 | GO:0052817 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDC42BPG HK1 TRIO KALRN MKNK2 OBSCN LMTK3 MAP3K3 MAP3K4 SBK1 CIITA COQ8A EPHA2 NRK MAP3K9 PNCK CDK3 | 7.17e-05 | 709 | 163 | 17 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDC42BPG HK1 TRIO KALRN MKNK2 OBSCN LMTK3 PARP14 TRRAP MAP3K3 MAP3K4 SBK1 CIITA COQ8A EPHA2 NRK GYS2 MAP3K9 PNCK CDK3 | 8.24e-05 | 938 | 163 | 20 | GO:0016772 |
| GeneOntologyMolecularFunction | D-glucose binding | 1.82e-04 | 14 | 163 | 3 | GO:0005536 | |
| GeneOntologyMolecularFunction | DNA/RNA helicase activity | 3.93e-04 | 4 | 163 | 2 | GO:0033677 | |
| GeneOntologyMolecularFunction | cadherin binding | 4.85e-04 | 339 | 163 | 10 | GO:0045296 | |
| GeneOntologyMolecularFunction | TORC2 complex binding | 6.52e-04 | 5 | 163 | 2 | GO:1904841 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 6.71e-04 | 129 | 163 | 6 | GO:0035591 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 9.53e-04 | 24 | 163 | 3 | GO:0008093 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 1.35e-03 | 27 | 163 | 3 | GO:0004709 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 1.20e-06 | 25 | 159 | 5 | GO:0045737 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein kinase activity | 2.18e-06 | 28 | 159 | 5 | GO:1904031 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | DOCK1 SOX9 ANK2 CNTNAP1 OBSCN FRS2 OBSL1 CASQ2 BIN3 IGF2 ADRB1 NFATC1 NFATC4 ANHX CDH2 | 1.61e-05 | 531 | 159 | 15 | GO:0042692 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | DOCK1 SOX9 ANK2 DSCAM CNTNAP1 OBSCN FRS2 OBSL1 SOX18 RNF213 CASQ2 ST14 MAP3K3 AXIN1 FMNL3 SOX7 IGF2 RPL7L1 NFATC1 NFATC4 EPHA2 CSPG4 KLHL12 SCRIB HERC1 IHH CDH11 | 2.47e-05 | 1483 | 159 | 27 | GO:0048646 |
| GeneOntologyBiologicalProcess | male germ-line sex determination | 5.91e-05 | 2 | 159 | 2 | GO:0019100 | |
| GeneOntologyBiologicalProcess | protein localization to M-band | 5.91e-05 | 2 | 159 | 2 | GO:0036309 | |
| GeneOntologyBiologicalProcess | primary sex determination, germ-line | 5.91e-05 | 2 | 159 | 2 | GO:0007542 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | SOX9 MRE11 DSCAM PARP14 MAP3K4 AXIN1 MPRIP MAVS CD86 EPHA2 CSPG4 SPDYE2 SPDYE5 SPDYE2B SPDYE6 SPDYE16 NCKAP1L | 1.13e-04 | 780 | 159 | 17 | GO:0042327 |
| GeneOntologyBiologicalProcess | muscle structure development | DOCK1 SOX9 SOX15 FLOT2 ANK2 CNTNAP1 OBSCN FRS2 OBSL1 CASQ2 BIN3 IGF2 ADRB1 NFATC1 NFATC4 ANHX ARID2 CDH2 | 1.14e-04 | 858 | 159 | 18 | GO:0061061 |
| GeneOntologyBiologicalProcess | axial mesoderm formation | 1.76e-04 | 3 | 159 | 2 | GO:0048320 | |
| GeneOntologyBiologicalProcess | primary sex determination | 1.76e-04 | 3 | 159 | 2 | GO:0007538 | |
| GeneOntologyBiologicalProcess | germ-line sex determination | 1.76e-04 | 3 | 159 | 2 | GO:0018992 | |
| GeneOntologyBiologicalProcess | muscle cell development | 1.87e-04 | 259 | 159 | 9 | GO:0055001 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 8.55e-05 | 94 | 160 | 6 | GO:0044291 | |
| Domain | Spy1 | 1.73e-10 | 11 | 162 | 6 | PF11357 | |
| Domain | Speedy | 1.73e-10 | 11 | 162 | 6 | IPR020984 | |
| Domain | Carbohydrate_sulfotransferase | 2.19e-05 | 7 | 162 | 3 | IPR016469 | |
| Domain | PROTEIN_KINASE_DOM | CDC42BPG TRIO KALRN MKNK2 OBSCN LMTK3 MAP3K3 MAP3K4 SBK1 COQ8A EPHA2 NRK MAP3K9 PNCK CDK3 | 2.65e-05 | 493 | 162 | 15 | PS50011 |
| Domain | PROTEIN_KINASE_ATP | CDC42BPG TRIO KALRN MKNK2 OBSCN LMTK3 MAP3K3 MAP3K4 SBK1 EPHA2 NRK MAP3K9 PNCK CDK3 | 4.84e-05 | 459 | 162 | 14 | PS00107 |
| Domain | Ser/Thr_kinase_AS | CDC42BPG TRIO KALRN MKNK2 OBSCN MAP3K3 MAP3K4 SBK1 NRK MAP3K9 PNCK CDK3 | 6.82e-05 | 357 | 162 | 12 | IPR008271 |
| Domain | S_TKc | CDC42BPG TRIO KALRN MKNK2 OBSCN MAP3K3 MAP3K4 SBK1 NRK MAP3K9 PNCK CDK3 | 7.19e-05 | 359 | 162 | 12 | SM00220 |
| Domain | K_chnl_inward-rec_Kir2.2 | 7.48e-05 | 2 | 162 | 2 | IPR003272 | |
| Domain | EIF3C_N_dom | 7.48e-05 | 2 | 162 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 7.48e-05 | 2 | 162 | 2 | PF05470 | |
| Domain | EIF3C | 7.48e-05 | 2 | 162 | 2 | IPR027516 | |
| Domain | Kinase-like_dom | CDC42BPG TRIO KALRN MKNK2 OBSCN TRRAP MAP3K3 MAP3K4 SBK1 COQ8A EPHA2 NRK MAP3K9 PNCK CDK3 | 7.77e-05 | 542 | 162 | 15 | IPR011009 |
| Domain | PROTEIN_KINASE_ST | CDC42BPG TRIO KALRN MKNK2 OBSCN MAP3K3 MAP3K4 SBK1 NRK MAP3K9 PNCK CDK3 | 7.79e-05 | 362 | 162 | 12 | PS00108 |
| Domain | Pkinase | CDC42BPG TRIO KALRN MKNK2 OBSCN MAP3K3 MAP3K4 SBK1 NRK MAP3K9 PNCK CDK3 | 1.26e-04 | 381 | 162 | 12 | PF00069 |
| Domain | K_chnl_inward-rec_Kir_N | 2.23e-04 | 3 | 162 | 2 | IPR013673 | |
| Domain | Sox_C | 2.23e-04 | 3 | 162 | 2 | IPR021934 | |
| Domain | Sox7/17/18_central | 2.23e-04 | 3 | 162 | 2 | IPR033392 | |
| Domain | IRK_N | 2.23e-04 | 3 | 162 | 2 | PF08466 | |
| Domain | Sox17_18_mid | 2.23e-04 | 3 | 162 | 2 | PF12067 | |
| Domain | SOX_C | 2.23e-04 | 3 | 162 | 2 | PS51516 | |
| Domain | Prot_kinase_dom | CDC42BPG TRIO KALRN MKNK2 OBSCN MAP3K3 MAP3K4 SBK1 EPHA2 NRK MAP3K9 PNCK CDK3 | 3.47e-04 | 489 | 162 | 13 | IPR000719 |
| Domain | P-loop_NTPase | MAGI1 CHST5 MRAS GBP1 RNF213 ATAD2 DHX9 CTPS2 CIITA STARD9 CHST4 HELZ2 ABCD1 CHST7 DNAH9 SNRNP200 PIF1 MPP7 | 4.16e-04 | 848 | 162 | 18 | IPR027417 |
| Domain | NFAT | 7.35e-04 | 5 | 162 | 2 | IPR008366 | |
| Pubmed | Murine fertility and spermatogenesis are independent of the testis-specific Spdye4a gene. | 2.81e-10 | 9 | 165 | 5 | 36272447 | |
| Pubmed | Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins. | 2.82e-09 | 13 | 165 | 5 | 15611625 | |
| Pubmed | MRE11 WDR36 PEG10 PRPF6 CCDC12 ATAD2 TRRAP TFCP2 DMAP1 MPRIP DHX9 RPL7L1 ARID2 PDCD11 LSM14A EIF3C SNRNP200 TOP2A RPL15 DCTN3 | 4.34e-09 | 847 | 165 | 20 | 35850772 | |
| Pubmed | Characterization of a new family of cyclin-dependent kinase activators. | 1.34e-08 | 17 | 165 | 5 | 15574121 | |
| Pubmed | FLOT2 DMXL2 KIFBP HK1 WDR36 ANK2 PEG10 FRS2 OBSL1 PRPF6 ME2 NDUFB10 TFCP2 CDKAL1 MPRIP DHX9 SPCS3 ESYT2 RPL7L1 EPHA2 PDCD11 SCRIB SNRNP200 MPP7 RPL15 | 4.00e-08 | 1487 | 165 | 25 | 33957083 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | MRE11 KIFBP HK1 PSMD5 PRPF6 TRRAP MAP3K4 DHX9 SPCS3 CTPS2 PDCD11 PDS5A EIF3C SCRIB ATP2A3 SNRNP200 TOP2A | 4.91e-08 | 704 | 165 | 17 | 29955894 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | MAGI1 FLOT2 ANK2 FRS2 PARP14 ATAD2 ADCY6 ST14 ESYT2 EPHA2 NRK CSPG4 SCRIB MPP7 IQCG | 1.02e-07 | 569 | 165 | 15 | 30639242 |
| Pubmed | DSCAM regulates delamination of neurons in the developing midbrain. | 1.57e-07 | 11 | 165 | 4 | 32917586 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CCNL2 TRIO MTHFD2 OBSL1 PSMD5 TRRAP MAP3K3 MAP3K4 AXIN1 EIF3CL MPRIP IGF2 NFATC4 EPHA2 NRK MAP3K9 EIF3C CDK3 | 3.74e-07 | 910 | 165 | 18 | 36736316 |
| Pubmed | CCNL2 MRE11 FLOT2 MTHFD2 NTAQ1 OBSL1 RNF213 SOWAHC TRRAP ADCY6 CDKAL1 DMAP1 SULF2 COQ8A ARID2 SCRIB PCCA AGBL1 IQCM TOP2A | 3.84e-07 | 1116 | 165 | 20 | 31753913 | |
| Pubmed | 4.71e-07 | 14 | 165 | 4 | 8921394 | ||
| Pubmed | FLOT2 HK1 TFCP2 AXIN1 DHX9 PDCD11 PYGL EIF3C SCRIB PCCA CDH2 TOP2A RPL15 | 6.10e-07 | 484 | 165 | 13 | 31995728 | |
| Pubmed | 6.40e-07 | 15 | 165 | 4 | 28512199 | ||
| Pubmed | 1.04e-06 | 5 | 165 | 3 | 30867513 | ||
| Pubmed | CDC42BPG PEG10 OBSL1 DHX9 MAVS COQ8A PYGL PDS5A SNRNP200 CDK3 | 1.12e-06 | 283 | 165 | 10 | 21903422 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.17e-06 | 220 | 165 | 9 | 35785414 | |
| Pubmed | DOCK1 MAGI1 MRE11 FLOT2 ANK2 FRS2 CDKAL1 DHX9 ESYT2 EPHA2 PDS5A SCRIB SNRNP200 MPP7 RPL15 | 1.60e-06 | 708 | 165 | 15 | 39231216 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MRE11 FLOT2 WDR36 PRPF6 NDUFB10 EIF3CL MPRIP DHX9 RPL7L1 KLHL7 SERPINB3 HELZ2 PDCD11 LSM14A SCRIB SNRNP200 TOP2A CBX8 RPL15 RAVER1 | 2.39e-06 | 1257 | 165 | 20 | 36526897 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MRE11 FLOT2 WDR36 ANK2 PARG ME2 TFCP2 MPRIP MAVS ARID2 LSM14A EIF3C SCRIB PCCA SNRNP200 TOP2A RPL15 | 2.47e-06 | 934 | 165 | 17 | 33916271 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | FLOT2 KIFBP HK1 WDR36 MTHFD2 OBSL1 RNF213 LARP4 ME2 NDUFB10 TFCP2 CDKAL1 DHX9 SPCS3 ESYT2 RPL7L1 MAVS ARID2 PDCD11 HERC1 TOP2A RAVER1 | 2.59e-06 | 1496 | 165 | 22 | 32877691 |
| Pubmed | Expression of Sox transcription factors in the developing mouse pancreas. | 2.74e-06 | 21 | 165 | 4 | 12815626 | |
| Pubmed | MRE11 HK1 WDR36 PRPF6 LARP4 ATAD2 TRRAP ME2 HELZ2 PDCD11 PYGL PDS5A SNRNP200 RPL15 | 3.15e-06 | 653 | 165 | 14 | 22586326 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MRE11 KIFBP PARG OBSL1 TRRAP TFCP2 DMAP1 ESYT2 NFATC1 NFATC4 SERPINB3 PDS5A SCRIB SNRNP200 TOP2A GAA | 3.60e-06 | 857 | 165 | 16 | 25609649 |
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 11181564 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MRE11 WDR36 PRPF6 CCDC12 TRRAP NDUFB10 TFCP2 CDKAL1 DMAP1 DHX9 ESYT2 RPL7L1 PDCD11 PDS5A PCCA SNRNP200 TOP2A CBX8 RPL15 RAVER1 | 3.69e-06 | 1294 | 165 | 20 | 30804502 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLOT2 DMXL2 HK1 KALRN PRPF6 LMTK3 TRRAP DMAP1 DHX9 SPCS3 SULF2 ARID2 HELZ2 PDS5A EIF3C SNRNP200 CBX8 RPL15 | 4.31e-06 | 1082 | 165 | 18 | 38697112 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MRE11 FLOT2 KIFBP HK1 WDR36 TRIO PRPF6 ATAD2 ME2 TFCP2 EIF3CL DHX9 RPL7L1 SERPINB3 STARD9 PDCD11 PDS5A EIF3C SNRNP200 TOP2A RPL15 | 4.33e-06 | 1425 | 165 | 21 | 30948266 |
| Pubmed | MRE11 PRPF6 PARP14 MPRIP DHX9 PDS5A SNRNP200 TOP2A RPL15 RAVER1 | 5.72e-06 | 340 | 165 | 10 | 24332808 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RIN3 TRIO KALRN SZT2 OBSCN FRMD8 TRRAP ST14 MPRIP MROH1 NFATC1 CSPG4 HELZ2 PDCD11 ABCD1 HERC1 ATP2A3 RASAL1 | 5.74e-06 | 1105 | 165 | 18 | 35748872 |
| Pubmed | FLOT2 TRIO FRS2 CDKAL1 MPRIP ESYT2 CTPS2 EPHA2 SCRIB CDH2 MPP7 | 5.96e-06 | 421 | 165 | 11 | 36976175 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 MAGI1 CDC42BPG TRIO OBSCN RNF213 CCDC12 LARP4 TRRAP ME2 SBK1 ESYT2 IGF2 NFATC1 COQ8A LSM14A PCCA ALG12 SLC2A11 DOP1A RAVER1 | 8.45e-06 | 1489 | 165 | 21 | 28611215 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | WDR36 PRPF6 LARP4 TRRAP MAP3K4 DMAP1 MPRIP DHX9 ARID2 SCRIB TOP2A | 9.02e-06 | 440 | 165 | 11 | 34244565 |
| Pubmed | 1.02e-05 | 103 | 165 | 6 | 10574462 | ||
| Pubmed | Sulfation of the human immunodeficiency virus envelope glycoprotein. | 1.23e-05 | 10 | 165 | 3 | 1433500 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FLOT2 WDR36 MTHFD2 OBSL1 PRPF6 LARP4 EIF3CL MPRIP DHX9 RPL7L1 PDCD11 EIF3C SCRIB SNRNP200 TOP2A RPL15 | 1.28e-05 | 949 | 165 | 16 | 36574265 |
| Pubmed | 1.30e-05 | 225 | 165 | 8 | 12168954 | ||
| Pubmed | SOX9 MRE11 SOX15 FLOT2 PEG10 LARP4 TRRAP TFCP2 DMAP1 MPRIP RPL7L1 NFATC4 ARID2 PDCD11 PDS5A LSM14A EIF3C HERC1 PCCA RAVER1 | 1.57e-05 | 1429 | 165 | 20 | 35140242 | |
| Pubmed | 1.61e-05 | 304 | 165 | 9 | 32235678 | ||
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 19429912 | ||
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 8419650 | ||
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 28323137 | ||
| Pubmed | FLOT2 KIFBP HK1 WDR36 MTHFD2 PSMB9 RNF213 PRPF6 NDUFB10 CDKAL1 ESYT2 RPL7L1 COQ8A PDCD11 PDS5A EIF3C SCRIB SNRNP200 TOP2A RAVER1 | 1.76e-05 | 1440 | 165 | 20 | 30833792 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 2.03e-05 | 313 | 165 | 9 | 38270169 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.05e-05 | 394 | 165 | 10 | 27248496 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MRE11 PARG ATAD2 TRRAP ADCY6 EIF3CL DHX9 ESYT2 HELZ2 EIF3C SCRIB SNRNP200 TOP2A RAVER1 | 2.13e-05 | 774 | 165 | 14 | 15302935 |
| Pubmed | FLOT2 upregulation promotes growth and invasion by interacting and stabilizing EphA2 in gliomas. | 2.24e-05 | 2 | 165 | 2 | 33631676 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 27893713 | ||
| Pubmed | Essential role of obscurin kinase-1 in cardiomyocyte coupling via N-cadherin phosphorylation. | 2.24e-05 | 2 | 165 | 2 | 38127465 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 36809926 | ||
| Pubmed | CDH2 and CDH11 act as regulators of stem cell fate decisions. | 2.24e-05 | 2 | 165 | 2 | 25771201 | |
| Pubmed | EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis. | 2.24e-05 | 2 | 165 | 2 | 36157221 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 37277529 | ||
| Pubmed | CREG inhibits migration of human vascular smooth muscle cells by mediating IGF-II endocytosis. | 2.24e-05 | 2 | 165 | 2 | 19769965 | |
| Pubmed | Role of Kir2.2 in hypercapnic ventilatory response during postnatal development of mouse. | 2.24e-05 | 2 | 165 | 2 | 15705530 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 18383368 | ||
| Pubmed | Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP. | 2.24e-05 | 2 | 165 | 2 | 26858404 | |
| Pubmed | SOX15 and SOX7 differentially regulate the myogenic program in P19 cells. | 2.24e-05 | 2 | 165 | 2 | 19489079 | |
| Pubmed | Ankyrin-B is required for intracellular sorting of structurally diverse Ca2+ homeostasis proteins. | 2.24e-05 | 2 | 165 | 2 | 10579720 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 24319099 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 7750650 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 20605916 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 15476585 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12107080 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 22440395 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 37510994 | ||
| Pubmed | RNA helicase A interacts with dsDNA and topoisomerase IIalpha. | 2.24e-05 | 2 | 165 | 2 | 12711669 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 28760926 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | PRPF6 TFCP2 DHX9 NFATC1 NFATC4 SERPINB3 PDCD11 PDS5A LSM14A EIF3C SCRIB SNRNP200 | 2.43e-05 | 583 | 165 | 12 | 29844126 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MRE11 HK1 WDR36 PSMD5 PRPF6 LARP4 ATAD2 TRRAP MPRIP DHX9 RPL7L1 SERPINB3 PDCD11 PYGL PDS5A SCRIB SNRNP200 TOP2A RPL15 | 2.49e-05 | 1353 | 165 | 19 | 29467282 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | MRE11 WDR36 PARP14 TRRAP DMAP1 FMNL3 EIF3C SCRIB SNRNP200 RPL15 | 2.87e-05 | 410 | 165 | 10 | 26949251 |
| Pubmed | Deciphering the Sox-Oct partner code by quantitative cooperativity measurements. | 2.90e-05 | 13 | 165 | 3 | 22344693 | |
| Pubmed | MRE11 WDR36 ANK2 PEG10 OBSL1 PRPF6 LARP4 TFCP2 MPRIP SPCS3 COQ8A STARD9 EPHA2 HELZ2 PDCD11 LSM14A KLHL12 CBX8 RPL15 | 2.98e-05 | 1371 | 165 | 19 | 36244648 | |
| Pubmed | DOCK1 KALRN SOWAHC DMAP1 EIF3CL MAVS EIF3C SCRIB TOP2A CDK3 RAVER1 | 3.09e-05 | 503 | 165 | 11 | 16964243 | |
| Pubmed | 3.36e-05 | 334 | 165 | 9 | 30425250 | ||
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 3.86e-05 | 262 | 165 | 8 | 36880596 | |
| Pubmed | SOX9 DMXL2 ANK2 DSCAM TRIO KALRN PEG10 CNTNAP1 OBSL1 NAP1L3 PSMD5 DMAP1 MPRIP KLHL7 EIF3C SCRIB SNRNP200 RPL15 | 4.25e-05 | 1285 | 165 | 18 | 35914814 | |
| Pubmed | 4.30e-05 | 195 | 165 | 7 | 19454010 | ||
| Pubmed | Trio controls the mature organization of neuronal clusters in the hindbrain. | 4.58e-05 | 15 | 165 | 3 | 17898204 | |
| Pubmed | Sox7, Sox17, and Sox18 Cooperatively Regulate Vascular Development in the Mouse Retina. | 4.58e-05 | 15 | 165 | 3 | 26630461 | |
| Pubmed | MAP3Ks as central regulators of cell fate during development. | 4.58e-05 | 15 | 165 | 3 | 18855897 | |
| Pubmed | Differential isoform expression and alternative splicing in sex determination in mice. | 4.58e-05 | 15 | 165 | 3 | 30871468 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 4.90e-05 | 271 | 165 | 8 | 32433965 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.38e-05 | 202 | 165 | 7 | 33005030 | |
| Pubmed | FLOT2 HK1 TRIO MTHFD2 MPRIP DHX9 ARID2 PDCD11 PDS5A TOP2A CBX8 RPL15 | 5.46e-05 | 634 | 165 | 12 | 34591612 | |
| Pubmed | Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. | 5.61e-05 | 16 | 165 | 3 | 16230076 | |
| Pubmed | MAGI1 DMXL2 KIFBP ANK2 DSCAM TRIO KALRN CNTNAP1 LMTK3 MPRIP KLHL7 SCRIB CDH2 CDH11 RASAL1 | 5.94e-05 | 963 | 165 | 15 | 28671696 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 30093410 | ||
| Pubmed | Enzymatic synthesis in vitro of the disulfated disaccharide unit of corneal keratan sulfate. | 6.69e-05 | 3 | 165 | 2 | 12218059 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 22763696 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 25623042 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 31801062 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 34570228 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 20624918 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 21489588 | ||
| Pubmed | Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex. | 6.69e-05 | 3 | 165 | 2 | 20133654 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 10904001 | ||
| Pubmed | Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line. | 6.69e-05 | 3 | 165 | 2 | 18782775 | |
| Pubmed | Perturbing cohesin dynamics drives MRE11 nuclease-dependent replication fork slowing. | 6.69e-05 | 3 | 165 | 2 | 29917110 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 27989621 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 17640933 | ||
| Interaction | RPS6KA2 interactions | 3.87e-06 | 196 | 160 | 10 | int:RPS6KA2 | |
| Interaction | KCNA3 interactions | DOCK1 MAGI1 MRE11 FLOT2 ANK2 SZT2 FRS2 RNF213 CDKAL1 MPRIP DHX9 ESYT2 EPHA2 PYGL PDS5A SCRIB SNRNP200 MPP7 DOP1A RPL15 | 1.97e-05 | 871 | 160 | 20 | int:KCNA3 |
| Interaction | LCK interactions | FLOT2 RIN3 TRIO KALRN MTHFD2 FRS2 OBSL1 CDKAL1 MPRIP EPHA2 SCRIB MPP7 RPL15 CDK3 | 2.04e-05 | 463 | 160 | 14 | int:LCK |
| Interaction | MEN1 interactions | MRE11 WDR36 PEG10 RNF213 PRPF6 CCDC12 PARP14 ATAD2 TRRAP TFCP2 DMAP1 DHX9 RPL7L1 ARID2 PDCD11 PDS5A EIF3C SNRNP200 TOP2A CBX8 RPL15 DCTN3 | 2.20e-05 | 1029 | 160 | 22 | int:MEN1 |
| Interaction | DOT1L interactions | WDR36 PEG10 PRPF6 CCDC12 ATAD2 TRRAP TFCP2 DMAP1 MPRIP DHX9 SOX7 RPL7L1 ARID2 PDCD11 LSM14A EIF3C SNRNP200 TOP2A RPL15 | 2.29e-05 | 807 | 160 | 19 | int:DOT1L |
| Interaction | PLAC1 interactions | 3.59e-05 | 24 | 160 | 4 | int:PLAC1 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 6.18e-07 | 12 | 110 | 4 | 756 | |
| GeneFamily | SRY-boxes | 4.69e-06 | 19 | 110 | 4 | 757 | |
| GeneFamily | Nuclear factors of activated T-cells | 3.62e-04 | 5 | 110 | 2 | 665 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 4.04e-04 | 24 | 110 | 3 | 654 | |
| GeneFamily | Sulfotransferases, membrane bound | 1.46e-03 | 37 | 110 | 3 | 763 | |
| GeneFamily | Dynein regulatory complex | 1.95e-03 | 11 | 110 | 2 | 981 | |
| GeneFamily | PDZ domain containing | 2.37e-03 | 152 | 110 | 5 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 2.96e-03 | 160 | 110 | 5 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.04e-03 | 161 | 110 | 5 | 593 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 4.16e-03 | 16 | 110 | 2 | 276 | |
| Coexpression | KIM_WT1_TARGETS_UP | SOX9 TRIO SOWAHC BIN3 IGF2 NFATC1 EPHA2 CSPG4 MAP3K9 CDH2 IQCG | 1.16e-07 | 217 | 162 | 11 | M9128 |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | DOCK1 SOX15 RIN3 TRIO MTHFD2 MKNK2 SOWAHC ST14 MAP3K3 SULF2 RPL7L1 MROH1 CIITA COQ8A CD86 EPHA2 EIF3C ABCD1 PCCA CBX8 MPP7 NCKAP1L | 9.60e-06 | 1250 | 162 | 22 | M41099 |
| Coexpression | GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP | 3.37e-05 | 198 | 162 | 8 | M4309 | |
| Coexpression | GSE14308_TH1_VS_NATURAL_TREG_DN | 3.49e-05 | 199 | 162 | 8 | M3381 | |
| Coexpression | HALLMARK_INTERFERON_GAMMA_RESPONSE | 3.62e-05 | 200 | 162 | 8 | M5913 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.78e-07 | 174 | 164 | 8 | 09b091e24317c3f7bac043f04762a533e30793de | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 4.08e-07 | 183 | 164 | 8 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-07 | 188 | 164 | 8 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-07 | 188 | 164 | 8 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.14e-07 | 197 | 164 | 8 | 8b9a88fb671d5c2b25d291c851e2b8a478f2610c | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 7.41e-07 | 198 | 164 | 8 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-mDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.04e-06 | 168 | 164 | 7 | 2dca1c4a33b6da9357fa3b2a523af19baab1c21c | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 3.28e-06 | 170 | 164 | 7 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-06 | 170 | 164 | 7 | 3cbeea6bfa500928c413b1c6129f6dedc769cd1e | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-06 | 176 | 164 | 7 | 24b2e94ee5defcefb64a1f2447a2cc71b015b0fd | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-06 | 178 | 164 | 7 | 7467e5ab2fcb39cc4a2c7dd69722c91def3b6aea | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.45e-06 | 178 | 164 | 7 | ea10117026021c959ffc871fc377cdb3e161d264 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.93e-06 | 186 | 164 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | frontal_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.10e-06 | 122 | 164 | 6 | c16110934172f174f4aefe14b81abce8514b30f0 | |
| ToppCell | frontal_cortex-Non-neuronal-pericyte_cell-Peri|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.10e-06 | 122 | 164 | 6 | 006ac4f6807e688554d36557d29d5e5a0bc3c36f | |
| ToppCell | frontal_cortex-Non-neuronal-pericyte_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.10e-06 | 122 | 164 | 6 | f3d9a5893fdee3562880fb6fc132b88169a7d997 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-06 | 188 | 164 | 7 | ab6fa1beff91584d9303c2a33735de89aae8d5cd | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 6.59e-06 | 189 | 164 | 7 | 533c302df467d13ab639232daf4f8cafb808260b | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-06 | 190 | 164 | 7 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 7.30e-06 | 192 | 164 | 7 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.35e-06 | 196 | 164 | 7 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 8.35e-06 | 196 | 164 | 7 | e1a9198bc51e01308f066323c5e089cfaf04b2ca | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.63e-06 | 197 | 164 | 7 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.63e-06 | 197 | 164 | 7 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.63e-06 | 197 | 164 | 7 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 8.92e-06 | 198 | 164 | 7 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | (00)_Basal-(1)_GFP|(00)_Basal / shred by cell type by condition | 9.22e-06 | 199 | 164 | 7 | 105b15157f35df3fdf857e306f11e4e8200e05d4 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.22e-06 | 199 | 164 | 7 | fcbb3a9c0f4c5b4c1f09db24b9f50cc1166fa43b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.22e-06 | 199 | 164 | 7 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 9.22e-06 | 199 | 164 | 7 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.22e-06 | 199 | 164 | 7 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_activated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.22e-06 | 199 | 164 | 7 | 82759af613ebfffe037afda55159bf6af812c3ac | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.53e-06 | 200 | 164 | 7 | 82126e25bfd8fba78dc1348fa5ad6a576289a139 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 137 | 164 | 6 | 587a369b148bb2600c06db39298feddfc99cb6ad | |
| ToppCell | MS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 2.14e-05 | 152 | 164 | 6 | b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 154 | 164 | 6 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.39e-05 | 155 | 164 | 6 | ced64e26962c5c6e6d539f361fe57ab0b399e999 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.39e-05 | 155 | 164 | 6 | 0f24ef6486aef354f0911c06932cb01d1a0525ac | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.39e-05 | 155 | 164 | 6 | d8b5145258f075b15080f8739f537f48dd22225e | |
| ToppCell | facs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 168 | 164 | 6 | d72cd8238fa793bb3e4add4c59eaaaadcea9930d | |
| ToppCell | facs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 168 | 164 | 6 | c34c52165485f612add7a3e35a175d5a6e365e7c | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-05 | 168 | 164 | 6 | a1755afa2cc50960ba60e07d84d61be429cdea72 | |
| ToppCell | facs-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 168 | 164 | 6 | d2afc097ae1243574210be6a751685f949ea941a | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-mDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.28e-05 | 172 | 164 | 6 | cc0e2a45fa74ee19e41612c3615729462474003a | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-05 | 173 | 164 | 6 | d78397e65e997ddb995111a810f0e2a4f67d0765 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-05 | 173 | 164 | 6 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-05 | 173 | 164 | 6 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-05 | 173 | 164 | 6 | 3c852ffe22f4a5b632463086b08c669310684e80 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-05 | 174 | 164 | 6 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-05 | 174 | 164 | 6 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 175 | 164 | 6 | d8e385320f554d974538b7cdc4f8e4767f1455f2 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 175 | 164 | 6 | cf15465855602ba135752c18755e3e058dbd42ec | |
| ToppCell | facs-Trachea-24m-Hematologic-lymphocytic-B_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.86e-05 | 176 | 164 | 6 | 318dc722b95e269002fb01a0feb91c0c8539e150 | |
| ToppCell | facs-Trachea-24m-Hematologic-lymphocytic-B_cell-B_cell_of_the_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.86e-05 | 176 | 164 | 6 | f6891006d816309edabe75b2abf60675f2958e55 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 4.86e-05 | 176 | 164 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.02e-05 | 177 | 164 | 6 | f360f7099570d248531897b96e0de282e58f59e9 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 5.34e-05 | 179 | 164 | 6 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.34e-05 | 179 | 164 | 6 | ce95b601bf17ae8167d382a105384b9e65e9407f | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-05 | 182 | 164 | 6 | d5d6bc16458bc665e7ad6669040d79f73f640044 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-05 | 182 | 164 | 6 | 0b59ead4bb4486c7ec2ee90b94ee3a09905612c5 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.22e-05 | 184 | 164 | 6 | 315bb14e848d8e8e4533122047df6f9b89b89d99 | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.41e-05 | 185 | 164 | 6 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 6.41e-05 | 185 | 164 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.61e-05 | 186 | 164 | 6 | 80a0a42ca8585cdb1dda57a18c254316a126ee64 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.80e-05 | 187 | 164 | 6 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Control / Disease state, Lineage and Cell class | 7.01e-05 | 188 | 164 | 6 | f5b7dbc89f992c13280d36a34935be83906b1bc0 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.01e-05 | 188 | 164 | 6 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-05 | 188 | 164 | 6 | 7471c194276161422326647f09022e94f3d1640c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-05 | 188 | 164 | 6 | 053c251d3ddbeb866f34565aefca4535517b4387 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.01e-05 | 188 | 164 | 6 | a11b12f1857953bcdbfb5f25e127f2350c39567d | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-05 | 188 | 164 | 6 | d2d2b6c49448da24f457cedcd213f68841834a99 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 7.22e-05 | 189 | 164 | 6 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 7.22e-05 | 189 | 164 | 6 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 7.65e-05 | 191 | 164 | 6 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.65e-05 | 191 | 164 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 7.65e-05 | 191 | 164 | 6 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 191 | 164 | 6 | ece87127f85939e61b1048d968ed96f0e87c3a79 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 191 | 164 | 6 | 478e8341ee03b05501e2233e02cef5f97492c95d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-05 | 192 | 164 | 6 | b18ae7337eaad1315a5b0ee81c75f7606bd3c7fe | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 7.87e-05 | 192 | 164 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | CV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 7.87e-05 | 192 | 164 | 6 | 2a2052b44e8f679ef484f03ba4fb37b0ec841b88 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.10e-05 | 193 | 164 | 6 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.10e-05 | 193 | 164 | 6 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 8.10e-05 | 193 | 164 | 6 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 8.10e-05 | 193 | 164 | 6 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.10e-05 | 193 | 164 | 6 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-05 | 193 | 164 | 6 | b397c14ac1e34c6be3f25d4417d200bc518d3048 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-myofibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.10e-05 | 193 | 164 | 6 | 02dfd1df1e7fc84bfca2b0c95138b5b4408bb5d1 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.10e-05 | 193 | 164 | 6 | 44839a606ae2f8e37421bda46d588189e1c943d2 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.10e-05 | 193 | 164 | 6 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.33e-05 | 194 | 164 | 6 | e36d1fd141bdcbd9ed66a33de6cdfde77189a0c1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.33e-05 | 194 | 164 | 6 | e55dc30e200c9f576804acb642175eb4fa9146b5 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.57e-05 | 195 | 164 | 6 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 8.57e-05 | 195 | 164 | 6 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 8.57e-05 | 195 | 164 | 6 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-D|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.82e-05 | 196 | 164 | 6 | 99953fe0a40e242f6945150345fc0a08ed95f8f9 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_monocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.82e-05 | 196 | 164 | 6 | 89ff93cbfbe39fbdf2498e8fdc5d61a0ecb26fc9 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.82e-05 | 196 | 164 | 6 | 09574bfeb1d3da53b5471cfb0602946d328b3b5c | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 8.82e-05 | 196 | 164 | 6 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-D-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.82e-05 | 196 | 164 | 6 | 5edffdc4c1ff35d9ee0e5c1bed0dc0c90b76ea00 | |
| Disease | platelet component distribution width | RIN3 LNX2 KALRN PSMB9 ZNF496 MPRIP ADRB1 MAVS PDS5A DLEC1 HERC1 EXOC3L2 ALG12 GAA PIF1 | 1.23e-05 | 755 | 156 | 15 | EFO_0007984 |
| Disease | PR interval | 3.19e-04 | 495 | 156 | 10 | EFO_0004462 | |
| Disease | Glycogen Storage Disease | 3.86e-04 | 27 | 156 | 3 | C0017919 | |
| Disease | Hepatoblastoma | 4.11e-04 | 6 | 156 | 2 | C0206624 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 5.30e-04 | 30 | 156 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | lethal congenital contracture syndrome (is_implicated_in) | 5.73e-04 | 7 | 156 | 2 | DOID:0060558 (is_implicated_in) | |
| Disease | intestinal cancer (implicated_via_orthology) | 6.42e-04 | 32 | 156 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Ventricular Dysfunction | 7.62e-04 | 8 | 156 | 2 | C0242973 | |
| Disease | glycogen storage disease (is_implicated_in) | 9.76e-04 | 9 | 156 | 2 | DOID:2747 (is_implicated_in) | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 1.22e-03 | 10 | 156 | 2 | C1631597 | |
| Disease | venous thromboembolism, response to antineoplastic agent | 1.33e-03 | 41 | 156 | 3 | EFO_0004286, GO_0097327 | |
| Disease | aortic valve stenosis (is_marker_for) | 1.48e-03 | 11 | 156 | 2 | DOID:1712 (is_marker_for) | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 1.48e-03 | 11 | 156 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Gastric Adenocarcinoma | 1.75e-03 | 45 | 156 | 3 | C0278701 | |
| Disease | Disease Exacerbation | 1.88e-03 | 165 | 156 | 5 | C0235874 | |
| Disease | spontaneous preterm birth | 2.06e-03 | 101 | 156 | 4 | EFO_0006917 | |
| Disease | Birth Weight | 2.42e-03 | 14 | 156 | 2 | C0005612 | |
| Disease | Down syndrome (implicated_via_orthology) | 2.79e-03 | 15 | 156 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | infant head circumference | 2.79e-03 | 15 | 156 | 2 | EFO_0004577 | |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 2.79e-03 | 15 | 156 | 2 | C2930967 | |
| Disease | cancer (implicated_via_orthology) | 3.10e-03 | 268 | 156 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | Hypertrophic Cardiomyopathy | 3.44e-03 | 57 | 156 | 3 | C0007194 | |
| Disease | insulin resistance | 3.79e-03 | 59 | 156 | 3 | EFO_0002614 | |
| Disease | femoral neck bone mineral density | 3.95e-03 | 196 | 156 | 5 | EFO_0007785 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 4.02e-03 | 18 | 156 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | Adrenocortical carcinoma | 4.02e-03 | 18 | 156 | 2 | C0206686 | |
| Disease | progression free survival, ovarian carcinoma | 4.02e-03 | 18 | 156 | 2 | EFO_0001075, EFO_0004920 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 4.48e-03 | 19 | 156 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | osteoporosis (implicated_via_orthology) | 4.48e-03 | 19 | 156 | 2 | DOID:11476 (implicated_via_orthology) | |
| Disease | type 1 diabetes mellitus (biomarker_via_orthology) | 4.48e-03 | 19 | 156 | 2 | DOID:9744 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKAFHRELVPDRLFV | 346 | P08588 | |
| PDIRQKHVAALLDIR | 311 | Q2M3D2 | |
| FIHNPKRQDLEVEVR | 591 | A0FGR8 | |
| EIQRFLRKHLIPDVT | 401 | Q14032 | |
| RHLVKRQREPAAAAV | 521 | Q5SNV9 | |
| VEVTTPVHDFLKRRN | 1356 | Q96N23 | |
| EINVKQARLRVDHRP | 881 | P78357 | |
| HLPAIIFVTKRNREV | 61 | O15467 | |
| FTQEDLRKRRVLFVH | 1081 | Q6UVK1 | |
| ILPKDVAAHFLARER | 951 | O43306 | |
| DEVFSHILKRPDRVL | 481 | P33076 | |
| RRRHKVLVGEFAQIR | 366 | Q96DY2 | |
| LAFPKIERRREIAHV | 26 | Q86TY3 | |
| FNNRTDRVKVILHPE | 466 | P54840 | |
| VRRPAEAEAHRIQQI | 286 | Q14254 | |
| LRTVFPNHTVKRVED | 571 | Q68CP9 | |
| LEVRRQGIHQREFKP | 2336 | Q5JWR5 | |
| HREDKVIPVTRSLRA | 121 | Q6PL18 | |
| PVLSEDIDKHRRRFN | 2406 | Q8TDJ6 | |
| IHIPERSDEAQRVFK | 301 | P42081 | |
| RLIRSFEHRNFKPVV | 11 | Q3KRA6 | |
| EKIAHDLRFVRLPVA | 601 | P00736 | |
| FARVEPAHKSRIVEN | 676 | Q93084 | |
| NRKVSVVRALRHAVP | 201 | Q9BV10 | |
| QRLLERTKNERAHPV | 1001 | Q96MI9 | |
| VHRNFPDISRVKSVR | 51 | Q9NPF8 | |
| PEIRHRGRFAVEFNK | 131 | Q9H095 | |
| FKQLHRRVEERFPQA | 441 | O95294 | |
| KAFHDLVRVIRQQIP | 166 | O14807 | |
| PEEIRKRLEHTERQF | 41 | Q8IY67 | |
| RFNDIHVPVRLESVK | 331 | Q29RF7 | |
| VDSKPELQRVLEHRR | 61 | O95990 | |
| APEFIKVRENLRRIA | 121 | O95990 | |
| KRIGPHIEIFQVFRE | 266 | A0A1B0GVH7 | |
| VIHAQSRDLPRIFRV | 1016 | Q6DT37 | |
| RCHFKRPRELEDAQA | 431 | P33897 | |
| VVFAKSHDPIEARLR | 1331 | Q01484 | |
| AVQLHVKEPRLRFTR | 331 | O75147 | |
| PNHRRSQVIEKFEAL | 296 | Q6WCQ1 | |
| QADRKFQEREVPCHR | 496 | Q7Z434 | |
| HVNLTVRRKVVFAVP | 916 | Q96QZ7 | |
| AHVRAQLIKPRVTEE | 226 | Q14500 | |
| RRNVFFPKRRELQIH | 126 | Q9BZ67 | |
| KRVIFHDPDLVEINR | 636 | A6NM62 | |
| NPHDRVVALRRVTAA | 3166 | Q15751 | |
| NSPREEIFQVALHKR | 331 | Q8N448 | |
| AFVVRQQHVKLARPR | 361 | Q96Q04 | |
| EKQPGHIRSRVFREV | 116 | Q9HBH9 | |
| ERDQQEEKHGPRRRF | 421 | A8MYZ0 | |
| RRVLDPKDAHVQFRV | 36 | Q86W56 | |
| DRPVTLVREFIERQH | 36 | O96000 | |
| ACFIERRKHQNDVRP | 2956 | O60229 | |
| KHFQERRLALRRPEI | 291 | Q5T2T1 | |
| KNTRVRLVFRVHVPQ | 556 | O95644 | |
| HVFEDPQRREVAKRK | 156 | Q86TG7 | |
| PVHREKAEIIRFLTN | 76 | P55160 | |
| RATPRHIIVRFTKVE | 211 | Q9UN81 | |
| HRRAEVHKVSRPENE | 236 | Q8ND56 | |
| FVFDRPVHRRKLAQL | 236 | P32455 | |
| QERKIPAHRVVLAAA | 51 | Q8IXQ5 | |
| VVNRVFDKLSPLHER | 46 | P28065 | |
| DRLLIEKFIDNPRHI | 256 | P05165 | |
| HVAARAPRELVLAKV | 746 | Q8NDA8 | |
| RFHKTLRRLVPDSDV | 426 | P19367 | |
| RQHTKEINDRRARFP | 231 | Q9Y2T5 | |
| DRPLQVFHVEVKVRD | 111 | Q9Y5I0 | |
| FIRHLLERDPQKRFT | 246 | Q6P2M8 | |
| SIVRVHARPVRFQEA | 3176 | Q5VST9 | |
| HARPVRFQEALKDLE | 3181 | Q5VST9 | |
| SHFRIEKIERIQNPD | 1641 | Q460N5 | |
| NLEPAIFEARRHVVK | 431 | Q3MJ16 | |
| PNIVRLLDVVHNERK | 61 | Q00526 | |
| EQEKVERRRQVPFHL | 661 | Q99613 | |
| IKAVPEHAARLQRLA | 116 | O75935 | |
| QEQEKVERRRQVPFH | 661 | B5ME19 | |
| PDAVHRERRRKAQEF | 126 | A4D2P6 | |
| EISKELHRLNFPRRA | 466 | Q9BYW1 | |
| TLRVEQKDFPAHRIV | 36 | Q53G59 | |
| AVDTFPARVIKHRAA | 276 | Q9HC52 | |
| KVAIPIEDVNRSHLR | 496 | Q14185 | |
| PVFDAGHERRRKEQL | 216 | Q9NPF5 | |
| AAILRRERQQKAPRH | 611 | Q5T197 | |
| DRHFVRKDVVPKVRR | 26 | Q5VV42 | |
| EAPRRIRDVINVFHR | 136 | Q96S94 | |
| RKNRTSVHVPLEARV | 206 | Q8WU20 | |
| QERARRPKFADIVSI | 856 | P29317 | |
| IAELRRRQAKEHRPV | 971 | Q8IVF7 | |
| VRVEPQKFAEELIHR | 381 | O15169 | |
| EPAKRLRAEQITVHA | 561 | A8TX70 | |
| LEAFREAKRHRPLIA | 146 | P01344 | |
| AKLHQAREELRPVRE | 156 | Q9NQY0 | |
| RHQEAKVPVAIRVLD | 466 | P55287 | |
| PHLAKIFERVRQSAD | 291 | Q8NI60 | |
| IRSIIPNHADKERFA | 111 | Q16829 | |
| ENRLHFTIKDPANRR | 176 | P10253 | |
| KIREQRRQFSHRAIP | 691 | Q71RC2 | |
| PKIETQDIQALRFHR | 56 | P23368 | |
| ELVEFVKEHQRPTLR | 236 | O14958 | |
| AEAPRVRAQHRERVT | 16 | Q02388 | |
| RRDPNFEALVRKAIV | 2106 | Q9NYC9 | |
| GEKHRELRLRNYVPE | 51 | Q8WUD4 | |
| PREDAARVARFVTHV | 51 | O75629 | |
| RADRQEAPRRVHLFV | 2056 | Q9BYK8 | |
| VEREIPGKRHRLQDF | 1436 | Q9Y238 | |
| VHRDIKPENVLLFDR | 171 | Q52WX2 | |
| VTKPLDREQIARFHL | 221 | P19022 | |
| PVAQRAVRLAVIEFH | 86 | Q96EK5 | |
| THNPLVNVRVERFKR | 876 | P80192 | |
| DIHPQFRRKFRVIRA | 121 | Q96HA8 | |
| LHSQIPREEQRKVFD | 686 | Q08211 | |
| FLDREPHRLRAFQVI | 246 | Q14623 | |
| RIKFEHNGERRIIAF | 46 | Q99759 | |
| EKFAVERPQAHRLFV | 911 | Q8TB24 | |
| RARIALVKNDRPVEF | 556 | Q9Y6R4 | |
| PFVRDIKNERHVVES | 311 | Q7Z2Y5 | |
| IRSQDVHIKAVLREP | 111 | O60469 | |
| NERRLQELPGKVHRF | 436 | Q9H611 | |
| EEILRLRFPHRVQSK | 686 | Q5T011 | |
| AHVRAQLIKPRVTEE | 226 | B7U540 | |
| KRPYVDEAERLRLQH | 91 | Q9BT81 | |
| KNTRVRLVFRVHVPQ | 546 | Q14934 | |
| RPFHLAAVRNEAVVI | 26 | P13995 | |
| PDKHSLAFVVRIERI | 91 | Q6DKI1 | |
| HVHLRVPFVAIRNKE | 916 | Q9UPU3 | |
| RVLRKALEHVPNSVR | 391 | O94906 | |
| AFKDRSVPVRLHVSR | 31 | P61009 | |
| VAHSSVFRVLRRPQE | 156 | Q969X2 | |
| PLQVARECLFHREKR | 191 | Q9BXF9 | |
| AVRETHKRVPEERLQ | 276 | Q99457 | |
| PEQRARARAHFKELV | 46 | Q53LP3 | |
| APVRTAKAERRHQER | 1456 | Q14160 | |
| KRPFVEEAERLRVQH | 151 | P48436 | |
| KEAVRRHINVSFALP | 1706 | Q9P2P6 | |
| VDRVANPKDIIHFFR | 386 | P49959 | |
| HEAFNRLLEDPVIKR | 196 | A6NHP3 | |
| RETRVDLHLPRFKVE | 276 | P29508 | |
| DVIVHARPIRTRASK | 256 | Q6UX72 | |
| LRRFAVPLHVDKNAE | 356 | Q9HAY6 | |
| RNFPREVREKLHNFA | 141 | E9PGG2 | |
| VHLVRDPRAVFRSRE | 201 | Q8NCG5 | |
| RHALPFTKILRVQEV | 356 | Q9GZS9 | |
| LKVVQLFRDPRAVHN | 271 | Q9NS84 | |
| RVHPNFRLIVIEEKD | 3141 | Q63HN8 | |
| DIFERVIHLSLAPKR | 1816 | Q14690 | |
| ERHRHRFEVNPNLIK | 476 | Q9NRF8 | |
| RPFVEEAKRLRARHL | 96 | O60248 | |
| VKSIFRVVFHDRRLQ | 116 | Q12800 | |
| EVILIDPFHKAIRRN | 131 | P61313 | |
| HEAFNRLLEDPVIKR | 156 | A6NNV3 | |
| HEAFNRLLEDPVIKR | 196 | P0DV79 | |
| HEAFNRLLEDPVIKR | 196 | A0A494C086 | |
| HEAFNRLLEDPVIKR | 196 | Q495Y8 | |
| HEAFNRLLEDPVIKR | 196 | A6NIY4 | |
| HEAFNRLLEDPVIKR | 196 | P0CI01 | |
| ERRLKRIISHPFFND | 691 | Q9Y5Y6 | |
| RPNRQLERLVSHIKE | 91 | O75679 | |
| RRQRKGYEEVHVPAL | 436 | O75643 | |
| RHRFLEEFITPIVKV | 566 | P11388 | |
| FIRHLRSRREQEKPH | 421 | Q96IT1 | |
| EPVHVARNLRVDLQR | 76 | Q16401 | |
| HEAFNRLLEDPVIKR | 156 | A6NJR5 | |
| KRPFVEEAERLRVQH | 131 | P35713 | |
| HLDRIVALFPKDVDR | 411 | P06737 | |
| KRERAELHRPQALVF | 596 | Q6BDS2 | |
| FQKPIVLRILDTHRE | 31 | P0DJG4 | |
| PRVEIVQKHNTAARR | 3501 | Q9Y4A5 | |
| ILKLLDTERPVNRFH | 386 | Q8IWU5 | |
| PHQIKAEIASRRDRL | 86 | Q9ULE0 | |
| ERRKHQNDVRPIRSI | 3071 | O75962 | |
| NDIPHVVRFSALKRR | 81 | Q8NI36 | |
| AVRVAERNFPHKTVA | 196 | Q8N5Q1 |